MERCK & CO., INC. |
Market Closed -
Other stock markets
|
After market 04:42:32 pm | |||
| 126.1 USD | -2.63% |
|
127.8 | +1.39% |
ETFs positioned on Merck & Co., Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.68% | 7 M€ | +8.12% | - | |
| 0.67% | 205 M€ | -.--% | ||
| 0.67% | 8 M€ | +5.48% | - | |
| 0.67% | 206 M€ | -.--% | ||
| 0.64% | 5 M€ | -.--% | - | |
| 0.62% | 57 M€ | +22.89% | - | |
| 0.61% | 727 M€ | +8.57% | ||
| 0.56% | 7 M€ | +0.11% | - | |
| 0.56% | 50 M€ | +11.25% | ||
| 0.54% | 14 M€ | +16.19% | - | |
| 0.51% | 1 M€ | +3.03% | - | |
| 0.51% | 2,517 M€ | +12.90% | - | |
| 0.50% | 1,166 M€ | +0.26% | - | |
| 0.50% | 607 M€ | +0.05% | - | |
| 0.50% | 25 M€ | +4.13% | - | |
| 0.49% | 283 M€ | +21.77% | ||
| 0.46% | 9 M€ | +10.17% | - | |
| 0.40% | 571 M€ | +7.80% | - | |
| 0.39% | 391 M€ | +8.93% | - | |
| 0.36% | 0 M€ | 0.00% | - | |
| 0.33% | 112 M€ | +4.44% | - |
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
Pharmaceuticals
Calendar
09:00am
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5
USD
Average target price
141.9
USD
Spread / Average Target
+9.57%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.66% | 328B | |
| +38.59% | 727B | |
| -7.89% | 354B | |
| +0.24% | 277B | |
| +13.47% | 243B | |
| +7.35% | 205B | |
| -6.42% | 203B | |
| +4.23% | 164B | |
| -1.70% | 164B | |
| -1.31% | 122B |
- Stock Market
- Equities
- MRK Stock
- Funds and ETFs Merck & Co., Inc.
